MILWAUKEE, Dec. 6, 2023 /PRNewswire/ — Ademi LLP is investigating Cerevel (NASDAQ: CERE) for possible breaches of fiduciary duty and other violations of law in its transaction with AbbVie. Click here to learn how to join the https://www.ademilaw.com/case/cerevel-therapeutics or call Guri…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.